Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) FCF Margin: 2014-2025

Historic FCF Margin for Ascendis Pharma A (ASND) over the last 12 years, with Sep 2025 value amounting to 1.01%.

  • Ascendis Pharma A's FCF Margin rose 9806.00% to 1.01% in Q3 2025 from the same period last year, while for Sep 2025 it was -15.82%, marking a year-over-year increase of 6419.00%. This contributed to the annual value of -84.20% for FY2024, which is 9194.00% up from last year.
  • Latest data reveals that Ascendis Pharma A reported FCF Margin of 1.01% as of Q3 2025, which was up 121.70% from -4.64% recorded in Q2 2025.
  • Ascendis Pharma A's 5-year FCF Margin high stood at 1.01% for Q3 2025, and its period low was -11,272.11% during Q2 2021.
  • Moreover, its 3-year median value for FCF Margin was -97.06% (2024), whereas its average is -135.69%.
  • Examining YoY changes over the last 5 years, Ascendis Pharma A's FCF Margin showed a top increase of 1,449,681bps in 2021 and a maximum decrease of 793,927bps in 2021.
  • Ascendis Pharma A's FCF Margin (Quarterly) stood at -2,559.08% in 2021, then soared by 194,023bps to -618.85% in 2022, then spiked by 58,801bps to -30.84% in 2023, then slumped by 1,928bps to -50.13% in 2024, then soared by 9,806bps to 1.01% in 2025.
  • Its FCF Margin was 1.01% in Q3 2025, compared to -4.64% in Q2 2025 and -14.18% in Q1 2025.